{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T06:30:44Z","timestamp":1792564244524,"version":"4.5.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Addictive Behaviors"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.addbeh.2021.107158","type":"journal-article","created":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T19:42:30Z","timestamp":1634845350000},"page":"107158","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Prevalences of and characteristics associated with single- and polydrug-involved U.S. Emergency Department Visits in 2018"],"prefix":"10.1016","volume":"125","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3154-2374","authenticated-orcid":false,"given":"Cassandra M.","family":"Pickens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6738-8703","authenticated-orcid":false,"given":"Brooke E.","family":"Hoots","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon M.","family":"Casillas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2260-2788","authenticated-orcid":false,"given":"Lawrence","family":"Scholl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.addbeh.2021.107158_b0005","unstructured":"Ahmad, F. B., Rossen, L. M., & Sutton, P. (2021). Provisional drug overdose death counts. National Center for Health Statistics. Accessed August 3, 2021, https:\/\/www.cdc.gov\/nchs\/nvss\/vsrr\/drug-overdose-data.htm#references."},{"issue":"2","key":"10.1016\/j.addbeh.2021.107158_b0010","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1056\/NEJMra1202561","article-title":"Management of opioid analgesic overdose","volume":"367","author":"Boyer","year":"2012","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.addbeh.2021.107158_b0015","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.drugpo.2017.05.023","article-title":"Exposure to fentanyl-contaminated heroin and overdose risk among illicit opioid users in Rhode Island: A mixed methods study","volume":"46","author":"Carroll","year":"2017","journal-title":"International Journal on Drug Policy"},{"key":"10.1016\/j.addbeh.2021.107158_b0020","unstructured":"Center for Behavioral Health Statistics and Quality. Results from the 2019 National Survey on Drug Use and Health: Detailed tables. Substance Abuse and Mental Health Services Administration. Accessed May 3, 2021, https:\/\/www.samhsa.gov\/data."},{"key":"10.1016\/j.addbeh.2021.107158_b0025","unstructured":"Centers for Disease Control and Prevention. (2013). Prescription Drug Overdose Data & Statistics. Guide to ICD-9-CM and ICD-10 Codes Related to Poisoning and Pain. Atlanta, GA."},{"key":"10.1016\/j.addbeh.2021.107158_b0030","unstructured":"Centers for Disease Control and Prevention. Preventing Suicide: A Technical Package of Policy, Programs, and Practices. 2017."},{"key":"10.1016\/j.addbeh.2021.107158_b0035","unstructured":"Centers for Disease Control and Prevention. Rising Numbers of Deaths Involving Fentanyl and Fentanyl Analogs, Including Carfentanil, and Increased Usage and Mixing with Non-opioids. Accessed March 24, 2021a, https:\/\/emergency.cdc.gov\/han\/han00413.asp."},{"key":"10.1016\/j.addbeh.2021.107158_b0040","unstructured":"Centers for Disease Control and Prevention. Overdose Data to Action. Accessed March 1, 2021b, https:\/\/www.cdc.gov\/drugoverdose\/od2a\/index.html."},{"key":"10.1016\/j.addbeh.2021.107158_b0045","unstructured":"Centers for Disease Control and Prevention. Increase in Fatal Drug Overdoses Across the United States Driven by Synthetic Opioids Before and During the COVID-19 Pandemic. April 6, 2021c. https:\/\/emergency.cdc.gov\/han\/2020\/han00438.asp."},{"key":"10.1016\/j.addbeh.2021.107158_b0050","unstructured":"Centers for Disease Control and Prevention. (2021). Nonfatal drug overdoses. Accessed March 1, 2021d, https:\/\/www.cdc.gov\/drugoverdose\/data\/nonfatal\/."},{"key":"10.1016\/j.addbeh.2021.107158_b0055","unstructured":"Centers for Disease Control and Prevention. Evidence-Based Strategies for Preventing Opioid Overdose: What\u2019s Working in the United States. National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, U.S. Department of Health and Human Services. Accessed March 23, 2021e, https:\/\/www.cdc.gov\/drugoverdose\/pdf\/pubs\/2018-evidence-based-strategies.pdf."},{"issue":"2","key":"10.1016\/j.addbeh.2021.107158_b0060","doi-asserted-by":"crossref","first-page":"244","DOI":"10.2105\/AJPH.2019.305412","article-title":"Polysubstance Use: A Broader Understanding of Substance Use During the Opioid Crisis","volume":"110","author":"Cicero","year":"2020","journal-title":"American Journal of Public Health"},{"issue":"S3","key":"10.1016\/j.addbeh.2021.107158_b0065","doi-asserted-by":"crossref","first-page":"S185","DOI":"10.2105\/AJPH.2019.305020","article-title":"Targeting Youth to Prevent Later Substance Use Disorder: An Underutilized Response to the US Opioid Crisis","volume":"109","author":"Compton","year":"2019","journal-title":"American Journal of Public Health"},{"issue":"1","key":"10.1016\/j.addbeh.2021.107158_b0070","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41380-020-00949-3","article-title":"Polysubstance use in the U.S. opioid crisis","volume":"26","author":"Compton","year":"2021","journal-title":"Molecular Psychiatry"},{"key":"10.1016\/j.addbeh.2021.107158_b0075","doi-asserted-by":"crossref","unstructured":"Dowell D, Haegerich TM, Chou R. CDC Guideline for Prescribing Opioids for Chronic Pain \u2014 United States, 2016. MMWR Recomm Rep. 2016;65(No. RR-1):1-49. doi:http:\/\/dx.doi.org\/10.15585\/mmwr.rr6501e1external.","DOI":"10.15585\/mmwr.rr6501e1er"},{"key":"10.1016\/j.addbeh.2021.107158_b0080","doi-asserted-by":"crossref","unstructured":"Gicquelais RE, Jannausch M, Bohnert ASB, Thomas L, Sen S, Fernandez AC. Links between suicidal intent, polysubstance use, and medical treatment after non-fatal opioid overdose. Drug Alcohol Depend. Jul 1 2020;212:108041. doi:10.1016\/j.drugalcdep.2020.108041.","DOI":"10.1016\/j.drugalcdep.2020.108041"},{"issue":"33","key":"10.1016\/j.addbeh.2021.107158_b0085","doi-asserted-by":"crossref","first-page":"837","DOI":"10.15585\/mmwr.mm6533a2","article-title":"Fentanyl Law Enforcement Submissions and Increases in Synthetic Opioid-Involved Overdose Deaths - 27 States, 2013\u20132014","volume":"65","author":"Gladden","year":"2016","journal-title":"MMWR Morbidity and Mortality Weekly Report"},{"key":"10.1016\/j.addbeh.2021.107158_b0090","doi-asserted-by":"crossref","first-page":"102661","DOI":"10.1016\/j.drugpo.2020.102661","article-title":"An assessment of the limits of detection, sensitivity and specificity of three devices for public health-based drug checking of fentanyl in street-acquired samples","volume":"77","author":"Green","year":"2020","journal-title":"International Journal on Drug Policy"},{"issue":"5","key":"10.1016\/j.addbeh.2021.107158_b0095","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.amepre.2019.06.007","article-title":"An Examination of Concurrent Opioid and Benzodiazepine Prescribing in 9 States, 2015","volume":"57","author":"Guy","year":"2019","journal-title":"American Journal of Preventive Medicine"},{"key":"10.1016\/j.addbeh.2021.107158_b0100","unstructured":"Healthcare Cost and Utilization Project. (2018). Introduction to the HCUP Nationwide Emergency Department Sample (NEDS). Accessed January 28, 2021, https:\/\/www.hcup-us.ahrq.gov\/db\/nation\/neds\/NEDS2018Introduction.pdf."},{"issue":"4","key":"10.1016\/j.addbeh.2021.107158_b0105","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1001\/jamapsychiatry.2020.4402","article-title":"Trends in US Emergency Department Visits for Mental Health, Overdose, and Violence Outcomes Before and During the COVID-19 Pandemic","volume":"78","author":"Holland","year":"2021","journal-title":"JAMA Psychiatry"},{"issue":"5","key":"10.1016\/j.addbeh.2021.107158_b0110","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1111\/add.14878","article-title":"The rise in non-fatal and fatal overdoses involving stimulants with and without opioids in the United States","volume":"115","author":"Hoots","year":"2020","journal-title":"Addiction"},{"issue":"166","key":"10.1016\/j.addbeh.2021.107158_b0115","article-title":"NCHS Urban-Rural Classification Scheme for Counties","volume":"2014;2","author":"Ingram","year":"2013","journal-title":"Vital and Health Statistics"},{"issue":"1","key":"10.1016\/j.addbeh.2021.107158_b0120","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1093\/epirev\/mxaa011","article-title":"The Evolving Overdose Epidemic: Synthetic Opioids and Rising Stimulant-Related Harms","volume":"42","author":"Jones","year":"2020","journal-title":"Epidemiologic Reviews"},{"issue":"4","key":"10.1016\/j.addbeh.2021.107158_b0125","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.amepre.2015.03.040","article-title":"Emergency Department Visits and Overdose Deaths From Combined Use of Opioids and Benzodiazepines","volume":"49","author":"Jones","year":"2015","journal-title":"American Journal of Preventive Medicine"},{"issue":"2","key":"10.1016\/j.addbeh.2021.107158_b0130","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/add.14812","article-title":"Increases in methamphetamine use among heroin treatment admissions in the United States, 2008\u201317","volume":"115","author":"Jones","year":"2020","journal-title":"Addiction"},{"issue":"17","key":"10.1016\/j.addbeh.2021.107158_b0135","doi-asserted-by":"crossref","first-page":"388","DOI":"10.15585\/mmwr.mm6817a3","article-title":"Drug Overdose Deaths Involving Cocaine and Psychostimulants with Abuse Potential - United States, 2003\u20132017","volume":"68","author":"Kariisa","year":"2019","journal-title":"MMWR Morbidity and Mortality Weekly Report"},{"issue":"34","key":"10.1016\/j.addbeh.2021.107158_b0140","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.15585\/mmwr.mm7034a2","article-title":"Multistate Trends in Nonfatal and Fatal Overdoses Involving Benzodiazepines, 2019\u20132020","volume":"70","author":"Liu","year":"2021","journal-title":"MMWR Morbidity and Mortality Weekly Report"},{"issue":"34","key":"10.1016\/j.addbeh.2021.107158_b0145","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.15585\/mmwr.mm6934a1","article-title":"Nonfatal Drug and Polydrug Overdoses Treated in Emergency Departments - 29 States, 2018\u20132019","volume":"69","author":"Liu","year":"2020","journal-title":"MMWR Morbidity and Mortality Weekly Report"},{"key":"10.1016\/j.addbeh.2021.107158_b0150","doi-asserted-by":"crossref","first-page":"106142","DOI":"10.1016\/j.addbeh.2019.106142","article-title":"A latent class analysis of drug and substance use patterns among patients treated in emergency departments for suspected drug overdose","volume":"101","author":"Liu","year":"2020","journal-title":"Addictive Behaviors"},{"issue":"2","key":"10.1016\/j.addbeh.2021.107158_b0155","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/02791072.2017.1394508","article-title":"Sold as Heroin: Perceptions and Use of an Evolving Drug in Baltimore, MD","volume":"50","author":"Mars","year":"2018","journal-title":"J Psychoactive Drugs. Apr-Jun"},{"issue":"6","key":"10.1016\/j.addbeh.2021.107158_b0160","doi-asserted-by":"crossref","first-page":"202","DOI":"10.15585\/mmwr.mm7006a4","article-title":"Trends and Geographic Patterns in Drug and Synthetic Opioid Overdose Deaths - United States, 2013\u20132019","volume":"70","author":"Mattson","year":"2021","journal-title":"MMWR Morbidity and Mortality Weekly Report"},{"key":"10.1016\/j.addbeh.2021.107158_b0165","unstructured":"National Institute on Drug Abuse, National Institutes of Health. Fentanyl DrugFacts. Accessed March 24, 2021, https:\/\/www.drugabuse.gov\/publications\/drugfacts\/fentanyl."},{"key":"10.1016\/j.addbeh.2021.107158_b0170","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.drugalcdep.2018.05.004","article-title":"Sociodemographic factors, prescription history and opioid overdose deaths: A statewide analysis using linked PDMP and mortality data","volume":"190","author":"Nechuta","year":"2018","journal-title":"Drug and Alcohol Dependence"},{"issue":"35","key":"10.1016\/j.addbeh.2021.107158_b0175","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.15585\/mmwr.mm6935a1","article-title":"Vital Signs: Characteristics of Drug Overdose Deaths Involving Opioids and Stimulants - 24 States and the District of Columbia, January-June 2019","volume":"69","author":"O'Donnell","year":"2020","journal-title":"MMWR Morbidity and Mortality Weekly Report"},{"issue":"5152","key":"10.1016\/j.addbeh.2021.107158_b0180","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.15585\/mmwr.mm675152e1","article-title":"Drug and Opioid-Involved Overdose Deaths - United States, 2013\u20132017","volume":"67","author":"Scholl","year":"2018","journal-title":"MMWR Morbidity and Mortality Weekly Report"},{"issue":"14","key":"10.1016\/j.addbeh.2021.107158_b0185","doi-asserted-by":"crossref","first-page":"382","DOI":"10.15585\/mmwr.mm6614a2","article-title":"Characteristics of Fentanyl Overdose - Massachusetts, 2014\u20132016","volume":"66","author":"Somerville","year":"2017","journal-title":"MMWR Morbidity and Mortality Weekly Report"},{"issue":"13","key":"10.1016\/j.addbeh.2021.107158_b0190","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1017\/S0033291717000691","article-title":"PROSPER delivery of universal preventive interventions with young adolescents: Long-term effects on emerging adult substance misuse and associated risk behaviors","volume":"47","author":"Spoth","year":"2017","journal-title":"Psychological Medicine"},{"issue":"2","key":"10.1016\/j.addbeh.2021.107158_b0195","doi-asserted-by":"crossref","first-page":"41","DOI":"10.15585\/mmwr.mm6802a4","article-title":"Notes from the Field: Fentanyl Drug Submissions - United States, 2010\u20132017","volume":"68","author":"Springer","year":"2019","journal-title":"MMWR Morbidity and Mortality Weekly Report"},{"key":"10.1016\/j.addbeh.2021.107158_b0200","unstructured":"Substance Abuse and Mental Health Services Administration (SAMSHA). Drug Abuse Warning Network, 2011: National Estimates of Drug-Related Emergency Department Visits. Substance Abuse and Mental Health Services Administration. Accessed March 23, 2021, https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/DAWN2k11ED\/DAWN2k11ED\/DAWN2k11ED.pdf."},{"key":"10.1016\/j.addbeh.2021.107158_b0205","article-title":"Association between concurrent use of prescription opioids and benzodiazepines and overdose: retrospective analysis","volume":"356","author":"Sun","year":"2017","journal-title":"Bmj"},{"key":"10.1016\/j.addbeh.2021.107158_b0210","unstructured":"U.S. Drug Enforcement Administration. 2020 Drug Enforcement Administration NDTA National Drug Threat Assessment. U.S. Department of Justice Drug Enforcement Administration. Accessed April 19, 2021, https:\/\/www.dea.gov\/sites\/default\/files\/2021-02\/DIR-008-21%202020%20National%20Drug%20Threat%20Assessment_WEB.pdf."},{"issue":"13","key":"10.1016\/j.addbeh.2021.107158_b0215","doi-asserted-by":"crossref","first-page":"371","DOI":"10.15585\/mmwr.mm6913a3","article-title":"Nonfatal Drug Overdoses Treated in Emergency Departments - United States, 2016\u20132017","volume":"69","author":"Vivolo-Kantor","year":"2020","journal-title":"MMWR Morbidity and Mortality Weekly Report"},{"key":"10.1016\/j.addbeh.2021.107158_b0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108323","article-title":"Recent trends and associated factors of amphetamine-type stimulant overdoses in emergency departments","volume":"216","author":"Vivolo-Kantor","year":"2020","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.addbeh.2021.107158_b0225","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.drugalcdep.2019.02.033","article-title":"The epidemiology of benzodiazepine misuse: A systematic review","volume":"200","author":"Votaw","year":"2019","journal-title":"Drug and Alcohol Dependence"},{"issue":"11","key":"10.1016\/j.addbeh.2021.107158_b0230","doi-asserted-by":"crossref","first-page":"290","DOI":"10.15585\/mmwr.mm6911a4","article-title":"Drug and Opioid-Involved Overdose Deaths - United States, 2017\u20132018","volume":"69","author":"Wilson","year":"2020","journal-title":"MMWR Morbidity and Mortality Weekly Report"},{"issue":"12","key":"10.1016\/j.addbeh.2021.107158_b0235","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1007\/s11606-012-2096-3","article-title":"Risk of unintentional overdose with non-prescription acetaminophen products","volume":"27","author":"Wolf","year":"2012","journal-title":"Journal of General Internal Medicine"},{"key":"10.1016\/j.addbeh.2021.107158_b0240","unstructured":"Injury Surveillance Workgroup 7. (April 2012). Consensus Recommendations for National and State Poisoning Surveillance. Atlanta, GA: The Safe States Alliance."},{"key":"10.1016\/j.addbeh.2021.107158_b0245","series-title":"International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM)","author":"World Health Organization","year":"1980"},{"key":"10.1016\/j.addbeh.2021.107158_b0250","series-title":"International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM)","author":"World Health Organization","year":"2015"},{"key":"10.1016\/j.addbeh.2021.107158_b0255","doi-asserted-by":"crossref","unstructured":"Wu AH, McKay C, Broussard LA, et al. National academy of clinical biochemistry laboratory medicine practice guidelines: recommendations for the use of laboratory tests to support poisoned patients who present to the emergency department. Clin Chem. Mar 2003;49(3):357-79. doi:10.1373\/49.3.357.","DOI":"10.1373\/49.3.357"}],"container-title":["Addictive Behaviors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306460321003439?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306460321003439?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T18:49:13Z","timestamp":1759690153000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306460321003439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":51,"alternative-id":["S0306460321003439"],"URL":"https:\/\/doi.org\/10.1016\/j.addbeh.2021.107158","relation":{},"ISSN":["0306-4603"],"issn-type":[{"value":"0306-4603","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalences of and characteristics associated with single- and polydrug-involved U.S. Emergency Department Visits in 2018","name":"articletitle","label":"Article Title"},{"value":"Addictive Behaviors","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addbeh.2021.107158","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107158"}}